Search
Sanara Medtech Inc
SMTIAdd to Watchlist
32.350USD
-0.190-0.58%
Close 11-13 16:00（ET）
297.30MMarket Cap
LossP/E TTM
Sanara Medtech Inc (SMTI) Stock Price Target & Forecast
Analyst Rating
Based on 3 analysts giving stock ratings to Sanara Medtech Inc in the past month.
Hold
0 Strong Buy
0 Buy
3 Hold
0 Sell
0 Strong Sell
Target Price
35.000USD+6.61%
SMTI Analyst Recommendation Trends
In the current month, SMTI has received 0 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. SMTI average Analyst price target in the last month is 35.000.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
0
0
0
0
0
0
0
0
0
0
1
3
2
2
1
2
3
3
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
3
3
3
2
2
1
2
SMTI Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Biogen Inc
BIIB
8
16
12
1
0
37
Amgen Inc
AMGN
4
9
19
3
1
36
Vertex Pharmaceuticals Inc
VRTX
10
17
5
0
1
33
Eli Lilly and Co
LLY
10
19
3
1
0
33
Alnylam Pharmaceuticals Inc
ALNY
7
17
8
0
0
32
AbbVie Inc
ABBV
8
18
6
0
0
32
Neurocrine Biosciences Inc
NBIX
13
14
4
0
0
31
Merck & Co Inc
MRK
7
16
8
0
0
31
Gilead Sciences Inc
GILD
7
18
5
0
0
30
Bristol-Myers Squibb Co
BMY
5
6
18
1
0
30
Financial Forecasting
Based on analysts' estimates, SMTI EPS is projected to reach 0.137 in FY2026Q4, following reported EPS of -0.161 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
-0.13
-0.03
0.06
0.14
0.14
Actual
0.05
-0.05
-0.16
--
--
Surprise
+140.55%
-109.12%
-367.85%
--
--
FAQs
What is Sanara Medtech Inc's expected revenue for the next quarter?
Sanara Medtech Inc's expected revenue is 30.70M.
What is Sanara Medtech Inc's price target?
Analysts forecast that Sanara Medtech Inc's price target is USD 35.00, with the highest forecast at USD 35.00 and the lowest forecast at USD 35.00.
How have Sanara Medtech IncSMTI's recent earnings per share performed?
The market expectation was USD -0.16, while Sanara Medtech IncSMTI's earnings per share (EPS) for the previous quarter was USD -0.05. EPS for the next quarter is expected at USD 0.14.
What is the analyst rating for Sanara Medtech Inc?
Based on the ratings of Sanara Medtech Inc's stock from 3 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.